🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Start Date
2023-02-01
Trial ID
NCT05662319
This is a first-in-human (FIH), Phase 1/2, 3-part open-label, dose escalati...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2025-02-06
Trial ID
NCT06754852
Patients with severe Haemophilia A need prophylactic factor VIII to reduce ...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2013-04
Trial ID
NCT02697370
Treatments Being Tested
The main objective of the study is to assess the pharmacokinetics of OPTIVA...
Status
Terminated
Location
Rambam Health Care Campus, 8 Haaliya St., Bat-Galim
Start Date
2006-11
Trial ID
NCT00387192
Treatments Being Tested
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
The objective of this study is to assess whether prophylactic therapy with ...
Status
Completed
Location
Tulane University School of Medicine
Start Date
2003-06
Trial ID
NCT00221195
Treatments Being Tested
Background: Joint haemorrhage represents the most common type of bleeding e...
Status
Completed
Location
Matteo Di Minno
Start Date
2022-03-01
Trial ID
NCT04784988
Treatments Being Tested
The investigators propose to study longitudinal joint and bone density chan...
Status
Recruiting
Location
Orthopedic Hemophilia Treatment Center
Start Date
2019-04-04
Trial ID
NCT04131036
Treatments Being Tested
The purpose of this phase 3 study is to investigate the efficacy and safety...
Status
Completed
Location
University of Colorado Health
Start Date
2017-11-16
Trial ID
NCT02973087
Treatments Being Tested